ANI Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ANIP Nasdaq 2834 www.anipharmaceuticals.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ANI Pharmaceuticals, Inc.

Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates - Aug 6th, 2026 3:40 pm
1 Healthcare Stock Worth Your Attention and 2 We Question - Aug 3rd, 2026 11:01 pm
TG Therapeutics (TGTX) Misses Q2 Earnings Estimates - Aug 3rd, 2026 6:10 am
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth - Jul 31st, 2026 8:00 am
The Bull Case For ANI Pharmaceuticals (ANIP) Could Change Following Positive ILUVIEN Phase 4 NIU-PS Data - Jul 25th, 2026 11:09 am
Is ANI Pharmaceuticals (ANIP) A Bargain Following Its Positive SYNCHRONICITY Trial Results? - Jul 24th, 2026 10:19 pm
2 Reasons to Watch ANIP and 1 to Stay Cautious - Jul 24th, 2026 2:01 pm
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds - Jul 24th, 2026 7:05 am
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET - Jul 24th, 2026 4:50 am
2 Small-Cap Stocks Worth Investigating and 1 We Brush Off - Jul 21st, 2026 3:02 am
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter - Jul 16th, 2026 2:34 pm
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis - Jul 13th, 2026 4:50 am
ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run - Jul 12th, 2026 6:40 pm
2 Value Stocks for Long-Term Investors and 1 We Avoid - Jul 10th, 2026 7:11 am